News Noom expands its GLP-1 range with 'microdose' package Noom is offering 'microdoses' of semaglutide at a knock-down price, claiming they can prevent side effects but remain effective for weight loss.
News Tech giants back unified health data-sharing platform in US The Trump administration wants to build an interoperable digital health platform for handling patient records, medical systems, and apps.
Digital Redefining relational primary healthcare: Harnessing the pow... If the NHS is to survive and thrive, we must explore alternative models of care that prioritise relationships over transactions.
News Medical chatbot firm OpenEvidence raises $210m OpenEvidence has raised $210m to expand the capabilities of its physician decision-making tool and launch a new service offering 'PhD-level' research.
News NHS trust rolls out digital health tool for kidney disease An NHS trust in England is starting a pilot study of a digital health platform that promises to improve the care of people with kidney disease.
News Paper gives hint of Apple's thinking on AI and health Apple is looking at combining AI and behavioural measurements in its health apps, but will the tech make it to a consumer device like the Apple Watch?
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.